Myoblast therapy: From bench to bedside

Cell Transplantation

Volumn 15, Issue 6, 2006, Pages 455-462

  Liu, Zhongmin ^a   Wu, Yanling ^a   Chen, Bing Guan ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Duchenne muscular dystrophy; Gene therapy; Incontinence; Myoblast therapy; Myocardiopathy

Indexed keywords

ANEMIA; CARCINOGENICITY; CARDIOMYOPATHY; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE TARGETING; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYBRID; INSULIN DEPENDENT DIABETES MELLITUS; MUSCLE CELL; MUSCLE DISEASE; MYOBLAST; NEUROPATHY; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; STRESS INCONTINENCE; SYSTEMATIC REVIEW; TRANSGENE; TREATMENT INDICATION; TREATMENT OUTCOME; URINE INCONTINENCE;

ANIMALS; CARDIOMYOPATHIES; GENE TRANSFER TECHNIQUES; HUMANS; MUSCULAR DYSTROPHY, DUCHENNE; MYOBLASTS, SKELETAL; TISSUE THERAPY; URINARY INCONTINENCE;

EID: 33750442572     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783981710     Document Type: Review

References (65)

1. Alessandri, G.; Pagano, S.; Bez, A.; Benetti, A.; Pozzi, S.; Iannolo, G.; Baronio, M.; Invernici, G.; Caruso, A.; Muneretto, C.; Bisleri, G.; Parati, E. Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 364: 1872-1883; 2004.
2. Azarnoush, K.; Maurel, A.; Sebbah, L.; Carrion, C.; Bissery, A.; Mandet, C.; Pouly, J.; Bruneval, P.; Hagege, A. A.; Menasche, P. Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha. J. Thorac. Cardiovasc. Surg. 130:173-179; 2005.
3. Baker, R. S.; Bonner, P. H.; Porter, J. D.; Madhat, M. N.; Gross, J. Myoblast transfer therapy in the treatment of ptosis: A preliminary study. J. Pediatr. Ophthalmol. Strabismus 30:113-117; 1993.
4. Baroffio, A.; Hamann, M.; Bernheim, L.; Bochaton-Piallat, M. L.; Gabbiani, G.; Bader, C. R. Identification of self-renewing myoblasts in the progeny of single human muscle satellite cells. Differentiation 60:47-57; 1996.
5. Beauchamp, J. R.; Morgan, J. E.; Pagel, C. N.; Partridge, T. A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144:1113-1122; 1999.
6. Belles-Isles, M.; Roy, R.; Dansereau, G.; Goulet, M.; Roy, B.; Bouchard, J. P.; Tremblay, J. P. Rapid selection of donor myoblast clones for muscular dystrophy therapy using cell surface expression of NCAM. Eur. J. Histochem. 37:375-380; 1993.
7. Benabdallah, B. F.; Bouchentouf, M.; Tremblay, J. P. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal. Transplantation 79: 1696-1702; 2005.
8. Bouchentouf, M.; Benabdallah, B. F.; Tremblay, J. P. Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation 77:1349-1356; 2004.
9. Brasselet, C.; Morichetti, M. C.; Messas, E.; Carrion, C.; Bissery, A.; Bruneval, P.; Vilquin, J. T.; Lafont, A.; Hagege, A. A.; Menasche, P.; Desnos, M. Skeletal myoblast transplantation through a catheter-based coronary sinus approach: An effective means of improving function of infarcted myocardium. Eur. Heart J. 26:1551-1556; 2005.
10. Chancellor, M. B.; Yokoyama, T.; Tirney, S.; Mattes, C. E.; Ozawa, H.; Yoshimura, N.; de Groat, W. C.; Huard, J. Preliminary results of myoblast injection into the urethra and bladder wall: A possible method for the treatment of stress urinary incontinence and impaired detrusor contractility. Neurourol. Urodyn. 19:279-287; 2000.
11. Collins, C. A.; Olsen, I.; Zammit, P. S.; Heslop, L.; Petrie, A.; Partridge, T. A.; Morgan, J. E. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122:289-301; 2005.
12. Cooper, R. N.; Irintchev, A.; Di Santo, J. P.; Zweyer, M.; Morgan, J. E.; Partridge, T. A.; Butler-Browne, G. S.; Mouly, V.; Wernig, A. A new immunodeficient mouse model for human myoblast transplantation. Hum. Gene Ther. 12:823-831; 2001.
13. Cooper, R. N.; Thiesson, D.; Furling, D.; Di Santo, J. P.; Butler-Browne, G. S.; Mouly, V. Extended amplification in vitro and replicative senescence: key factors implicated in the success of human myoblast transplantation. Hum. Gene Ther. 14:1169-1179; 2003.
14. Dahler, A.; Wade, R. P.; Muscat, G. E.; Waters, M. J. Expression vectors encoding human growth hormone (hGH) controlled by human muscle-specific promoters: prospects for regulated production of hGH delivered by myoblast transfer or intravenous injection. Gene 145:305-310; 1994.
15. Day, C. S.; Kasemkijwattana, C.; Menetrey, J.; Floyd, Jr., S. S.; Booth, D.; Moreland, M. S.; Fu, F. H.; Huard, J. Myoblast-mediated gene transfer to the joint. J. Orthop. Res. 15:894-903; 1997.
16. Dib, N.; McCarthy, P.; Campbell, A.; Yeager, M.; Pagani, F. D.; Wright, S.; MacLellan, W. R.; Fonarow, G.; Eisen, H. J.; Michler, R. E.; Binkley, P.; Buchele, D.; Korn, R.; Ghazoul, M.; Dinsmore, J.; Opie, S. R.; Diethrich, E. Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant. 14:11-19; 2005.
17. Dib, N.; Michler, R. E.; Pagani, F. D.; Wright, S.; Kereiakes, D. J.; Lengerich, R.; Binkley, P.; Buchele, D.; Anand, I.; Swingen, C.; Di Carli, M. F.; Thomas, J. D.; Jaber, W. A.; Opie, S. R.; Campbell, A.; McCarthy, P.; Yeager, M.; Dilsizian, V.; Griffith, B. P.; Korn, R.; Kreuger, S. K.; Ghazoul, M.; MacLellan, W. R.; Fonarow, G.; Eisen, H. J.; Dinsmore, J.; Diethrich, E. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Dour-year follow-up. Circulation 112:1748-1755; 2005.
18. Duan, D.; Yan, Z.; Yue, Y.; Ding, W.; Engelhardt, J. F. Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation. J. Virol. 75:7662-7671; 2001.
19. Furling, D.; Doucet, G.; Langlois, M. A.; Timchenko, L.; Belanger, E.; Cossette, L.; Puymirat, J. Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions. Gene Ther. 10:795-802: 2003.
20. Guerette, B.; Skuk, D.; Celestin, F.; Huard, C.; Tardif, F.; Asselin, I.; Roy, B.; Goulet, M.; Roy, R.; Entman, M.; Tremblay, J. P. Prevention by anti-LFA-1 of acute myoblast death following transplantation. J. Immunol. 159: 2522-2531; 1997.
21. Hagege, A. A.; Carrion, C.; Menasche, P.; Vilquin, J. T.; Duboc, D.; Marolleau, J. P.; Desnos, M.; Bruneval, P. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361:491-492; 2003.
22. Hamamori, Y.; Samal, B.; Tian, J.; Kedes, L. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J. Clin. Invest. 95:1808-1813; 1995.
23. Irintchev, A.; Zweyer, M.; Wernig, A. Cellular and molecular reactions in mouse muscles after myoblast implantation. J. Neurocytol. 24:319-331; 1995.
24. Laflamme, M. A.; Murry, C. E. Regenerating the heart. Nat. Biotechnol. 23:845-856; 2005.
25. Law, P. K.; Bertorini, T. E.; Goodwin, T. G.; Chen, M.; Fang, Q. W.; Li, H. J.; Kirby, D. S.; Florendo, J. A.; Herrod, H. G.; Golden, G. S. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 336:114-115; 1990.
26. Law, P. K.; Goodwin, T. G.; Fang, Q.; Duggirala, V.; Larkin, C.; Florendo, J. A.; Kirby, D. S.; Deering, M. B.; Li, H. J.; Chen, M.; et al. Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys. Cell Transplant. 1:235-244; 1992.
27. Law, P. K.; Goodwin, T. G.; Fang, Q.; Hall, T. L.; Quinley, T.; Vastagh, G.; Duggirala, V.; Larkin, C.; Florendo, J. A.; Li, L.; Jackson, T.; Yoo, T. J.; Chase, N.; Neel, M.; Krahn, T.; Holcomb, R. First human myoblast transfer therapy continues to show dystrophin after 6 years. Cell Transplant. 6:95-100; 1997.
28. Levenberg, S.; Rouwkema, J.; Macdonald, M.; Garfein, E. S.; Kohane, D. S.; Darland, D. C.; Marini, R.; van Blitterswijk, C. A.; Mulligan, R. C.; D'Amore, P. A.; Langer, R. Engineering vascularized skeletal muscle tissue. Nat. Biotechnol. 23:879-884; 2005.
29. Li, R. H.; Williams, S.; Burkstrand, M.; Roos, E. Encapsulation matrices for neurotrophic factor-secreting myoblast cells. Tissue Eng. 6:151-163; 2000.
30. McConnell, P. I.; del Rio, C. L.; Jacoby, D. B.; Pavlicova, M.; Kwiatkowski, P.; Zawadzka, A.; Dinsmore, J. H.; Astra, L.; Wisel, S.; Michler, R. E. Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure. J. Thorac. Cardiovasc. Surg. 130:1001; 2005.
31. Menasche, P. Myoblast transfer in heart failure. Surg. Clin. North Am. 84:125-139; 2004.
32. Menasche, P. Myoblast transplantation: feasibility, safety and efficacy. Ann. Med. 34:314-315; 2002.
33. Menasche, P. Skeletal myoblast for cell therapy. Coron. Artery Dis. 16:105-110; 2005.
34. Menasche, P.; Hagege, A. A.; Scorsin, M.; Pouzet, B.; Desnos, M.; Duboc, D.; Schwartz, K.; Vilquin, J. T.; Marolleau, J. P. Myoblast transplantation for heart failure. Lancet 357:279-280; 2001.
35. Menasche, P.; Hagege, A. A.; Vilquin, J. T.; Desnos, M.; Abergel, E.; Pouzet, B.; Bel, A.; Sarateanu, S.; Scorsin, M.; Schwartz, K.; Bruneval, P.; Benbunan, M.; Marolleau, J. P.; Duboc, D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41:1078-1083; 2003.
36. Mendell, J. R.; Kissel, J. T.; Amato, A. A.; King, W.; Signore, L.; Prior, T. W.; Sahenk, Z.; Benson, S.; McAndrew, P. E.; Rice, R.; et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333:832-838; 1995.
37. Miller, R. G.; Sharma, K. R.; Pavlath, G. K.; Gussoni, E.; Mynhier, M.; Lanctot, A. M.; Greco, C. M.; Steinman, L.; Blau, H. M. Myoblast implantation in Duchenne muscular dystrophy: The San Francisco study. Muscle Nerve 20: 469-478; 1997.
38. Neumeyer, A. M.; Cros, D.; McKenna-Yasek, D.; Zawadzka, A.; Hoffman, E. P.; Pegoraro, E.; Hunter, R. G.; Munsat, T. L.; Brown, Jr., R. H. Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy. Neurology 51:589-592; 1998.
39. Ott, H. C.; Kroess, R.; Bonaros, N.; Marksteiner, R.; Margreiter, E.; Schachner, T.; Laufer, G.; Hering, S. Intramyocardial microdepot injection increases the efficacy of skeletal myoblast transplantation. Eur. J. Cardiothorac. Surg. 27:1017-1021; 2005.
40. Ozawa, C. R.; Springer, M. L.; Blau, H. M. A novel means of drug delivery: myoblast-mediated gene therapy and regulatable retroviral vectors. Annu. Rev. Pharmacol. Toxicol. 40:295-317; 2000.
41. Pouly, J.; Hagege, A. A.; Vilquin, J. T.; Bissery, A.; Rouche, A.; Bruneval, P.; Duboc, D.; Desnos, M.; Fiszman, M.; Fromes, Y.; Menasche, P. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? Circulation 110:1626-1631; 2004.
42. Pouzet, B.; Ghostine, S.; Vilquin, J. T.; Garcin, I.; Scorsin, M.; Hagege, A. A.; Duboc, D.; Schwartz, K.; Menasche, P. Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors? Circulation 104:1223-228; 2001.
43. Pouzet, B.; Vilquin, J. T.; Hagege, A. A.; Scorsin, M.; Messas, E.; Fiszman, M.; Schwartz, K.; Menasche, P. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann. Thorac. Surg. 71:844-851; 2001.
44. Qu, Z.; Balkir, L.; van Deutekom, J. C.; Robbins, P. D.; Pruchnic, R.; Huard, J. Development of approaches to improve cell survival in myoblast transfer therapy. J. Cell Biol. 142:1257-1267; 1998.
45. Rando, T. A.; Blau, H. M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125:1275-1287; 1994.
46. Roman, M.; Axelrod, J. H.; Dai, Y.; Naviaux, R. K.; Friedmann, T.; Verma, I. M. Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle. Somat. Cell. Mol. Genet. 18:247-258; 1992.
47. Schneider, B. L.; Peduto, G.; Aebischer, P. A self-immunomodulating myoblast cell line for erythropoietin delivery. Gene Ther. 8:58-66: 2001.
48. Siminiak, T.; Kalawski, R.; Fiszer, D.; Jerzykowska, O.; Rzezniczak, J.; Rozwadowska, N.; Kurpisz, M. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am. Heart J. 148:531-537; 2004.
49. Simonson, G. D.; Groskreutz, D. J.; Gorman, C. M.; MacDonald, M. J. Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures. Hum. Gene Ther. 7:71-78; 1996.
50. Smythe, G. M.; Hodgetts, S. I.; Grounds, M. D. Problems and solutions in myoblast transfer therapy. J. Cell. Mol. Med. 5:33-47; 2001.
51. Steendijk, P.; Smits, P. C.; Valgimigli, M.; van der Giessen, W. J.; Onderwater, E. E.; Serruys, P. W. Intramyocardial injection of skeletal myoblasts: Long-term follow-up with pressure-volume loops. Nat. Clin. Pract. Cardiovasc. Med. 3(Suppl. 1):S94-S100; 2006.
52. Stewart, J. D.; Masi, T. L.; Cumming, A. E.; Molnar, G. M.; Wentworth, B. M.; Sampath, K.; McPherson. J. M.; Yaeger, P. C. Characterization of proliferating human skeletal muscle-derived cells in vitro: Differential modulation of myoblast markers by TGF-beta2. J. Cell. Physiol. 196:70-78; 2003.
53. Tambara, K.; Premaratne, G. U.; Sakaguchi, G.; Kanemitsu, N.; Lin, X.; Nakajima, H.; Sakakibara, Y.; Kimura, Y.; Yamamoto, M.; Tabata, Y.; Ikeda, T.; Komeda, M. Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft. Circulation 112:1129-134; 2005.
54. Taylor, D. A.; Atkins, B. Z.; Hungspreugs, P.; Jones, T. R.; Reedy, M. C.; Hutcheson, K. A.; Glower, D. D.; Kraus, W. E. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat. Med. 4:929-933; 1998.
55. Tirney, S.; Mattes, C. E.; Yoshimura, N.; Yokayama, T.; Ozawa, H.; Tzeng, E.; Birder, L. A.; Kanai, A. J.; Huard, J.; de Groat, W. C.; Chancellor, M. B. Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid, adenovirus, and adenovirus-transduced myoblast vectors. Mol. Urol. 5:37-43; 2001.
56. Torrente, Y.; D'Angelo, M. G.; Del Bo, R.; DeLiso, A.; Casati, R.; Benti, R.; Corti, S.; Comi, G. P.; Gerundini, P.; Anichini, A.; Scarlato, G.; Bresolin, N. Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice. Cell Transplant 8:247-258; 1999.
57. Tremblay, J. P.; Bouchard, J. P.; Malouin, F.; Theau, D.; Cottrell, F.; Collin, H.; Rouche, A.; Gilgenkrantz, S.; Abbadi, N.; Tremblay, M.; et al. Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromuscul. Disord. 3:583-592; 1993.
58. Tremblay, J. P.; Malouin, F.; Roy, R.; Huard, J.; Bouchard, J. P.; Satoh, A.; Richards, C. L. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 2:99-112; 1993.
59. Urish, K.; Kanda, Y.; Huard, J. Initial failure in myoblast transplantation therapy has led the way toward the isolation of muscle stem cells: Potential for tissue regeneration. Curr. Top. Dev. Biol. 68:263-280; 2005.
60. van den Bos, E. J.; Thompson, R. B.; Wagner, A.; Mahrholdt, H.; Morimoto, Y.; Thomson, L. E.; Wang, L. H.; Duncker, D. J.; Judd, R. M.; Taylor, D. A. Functional assessment of myoblast transplantation for cardiac repair with magnetic resonance imaging. Eur. J. Heart Fail. 7: 435-443; 2005.
61. von Degenfeld, G.; Banfi, A.; Springer, M. L.; Blau, H. M. Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis. Br. J. Pharmacol. 140:620-626; 2003.
62. Walsh, F. S. N-CAM is a target cell surface antigen for the purification of muscle cells for myoblast transfer therapy. Adv. Exp. Med. Biol. 280:41-46; 1990.
63. White, J. D.; Bower, J. J.; Kurek, J. B.; Austin, L. Leukemia inhibitory factor enhances regeneration in skeletal muscles after myoblast transplantation. Muscle Nerve 24: 695-697; 2001.
64. Yao, S. N.; Smith, K. J.; Kurachi, K. Primary myoblast-mediated gene transfer. Persistent expression of human factor IX in mice. Gene Ther. 1:99-107; 1994.
65. Yoshida, N.; Yoshida, S.; Koishi, K.; Masuda, K.; Nabeshima, Y. Cell heterogeneity upon myogenic differentiation: Down-regulation of MyoD and Myf-5 generates reserve cells'. J. Cell. Sci. 111(Pt. 6):769-779; 1998.